TuHURA Biosciences
HURA
27 hedge funds and large institutions have $11.8M invested in TuHURA Biosciences in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 4 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
34% more capital invested
Capital invested by funds: $8.84M → $11.8M (+$2.97M)
3.54% more ownership
Funds ownership: 5.11% → 8.64% (+3.5%)
0% more funds holding
Funds holding: 27 → 27 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.53M |
| 2 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
+$196K |
| 3 |
ST
Sabal Trust
St. Petersburg,
Florida
|
+$146K |
| 4 |
Jane Street
New York
|
+$78.9K |
| 5 |
I
INVST
Indianapolis,
Indiana
|
+$70.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$266K |
| 2 |
Squarepoint
New York
|
-$155K |
| 3 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$128K |
| 4 |
Millennium Management
New York
|
-$72.4K |
| 5 |
BlackRock
New York
|
-$63.2K |
HURA Hedge Fund Activity: Q1 2025 in Review
27 of the 7,466 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2025, worth a combined $11.8M — up 34% from $8.84M a quarter earlier.
Fund positioning in HURA was balanced in Q1 2025: 4 funds opened new positions, 4 closed out, 9 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $5.53M. The largest seller was Citigroup, exiting entirely with an estimated $266K sold.
- 27 institutional investors held TuHURA Biosciences (HURA) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $11.8M of TuHURA Biosciences stock for Q1 2025, up 34% quarter-over-quarter.
- 4 funds opened new TuHURA Biosciences positions in Q1 2025 and 4 closed out, a net change of 0 holders.
- The largest TuHURA Biosciences buyer in Q1 2025 was Vanguard Group, an estimated $5.53M added.
- The largest TuHURA Biosciences seller in Q1 2025 was Citigroup, an estimated $266K sold.
Based on aggregated 13F filings for Q1 2025.